Anti-Cetuximab Polyclonal Antibody|抗西妥昔单抗多克隆抗体(靶标：西妥昔单抗（抗EGFR单抗）)
- 货号：RB9TAF004014
- 价格：面议
- 点击：208
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA |
| 特异性 | The product is specific for Cetuximab. This antibody serves as an excellent positive control for Cetuximab immunogenicity (ADA) assays. |
| 靶标 | Rabbit polyclonal to Erbitux. |
| 免疫原 | Cetuximab |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 稳定性和储存 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | CAS: 205923-56-4 |
| 背景信息 | Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR. • Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies., PMID:36408164 • Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy., PMID:21255939 |
| 备注 | For research use only. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 心型脂肪酸结合蛋白鼠单抗 | 7415 |
| D-二聚体 G1 鼠单抗 | 7423 |
| D-二聚体 G2 鼠单抗 | 7646 |
| D-二聚体 G 鼠单抗 | 7298 |
| 抗人降钙素原鼠单抗 | 7461 |
| 抗人CRP鼠单抗 | 7297 |
| 抗人CRP鼠单抗-HRP | 7044 |
| 抗人SAA IgG鼠单抗 | 7543 |
| 抗生物素单抗 | 7322 |
| α-hcg单抗 | 7047 |
| β-hcg单抗 | 7152 |
| HIV配对鼠单抗 | 7334 |
| 脂蛋白小a鼠单抗 | 7287 |
| 红斑狼疮补体鼠单抗 | 7159 |
| 维生素D VDS鼠单抗 | 7303 |
| 二十五羟基维生素D3鼠单抗 | 7444 |
| 羊抗鼠抗体(定性) | 7105 |
| 羊抗鼠抗体(定量) | 7458 |
| RBC鼠单抗 | 7396 |
| HRP羊抗人抗体(精品) | 7304 |